AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 20,650
+100 (0.49%)
At close: Aug 6, 2025, 3:30 PM KST
AprilBio Revenue
AprilBio had revenue of 2.17B KRW in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to 29.69B. In the year 2024, AprilBio had annual revenue of 27.51B.
Revenue (ttm)
29.69B
Revenue Growth
n/a
P/S Ratio
15.25
Revenue / Employee
n/a
Employees
n/a
Market Cap
452.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.51B | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 200.00M | -23.20B | -99.15% |
| Dec 31, 2021 | 23.40B | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hanwha Aerospace | 15.28T |
| Hyundai Motor Company | 178.98T |
| Doosan Enerbility | 15.88T |
| HD Hyundai Heavy Industries | 15.32T |